Xeris Biopharma Reports Fourth Quarter and Full-year 2021 Financial Results and Recent Events

Go back to Xeris Biopharma Reports Fourth Quarter and Full-year 2021 Financial Results and Recent Events
(NASDAQ: XERS) Delayed: 7.20 +0.30 (4.35%)
Previous Close $6.90    52 Week High
Open $6.90    52 Week Low
Day High $7.30    P/E N/A 
Day Low $6.86    EPS
Volume 1,978,620